Yiling Pharmaceutical'S Patent Depression-Resolving Drug Approved For Marketing In China

Yiling Pharmaceutical'S Patent Depression-Resolving Drug Approved For Marketing In China

By, Admin 24 December 2021

According To Yiling Pharmaceutical'S Notice On Thursday (Utc+8), The Depression-Resolving And Restlessness-Relieving Capsules Have Been Approved For Marketing Via The Obtained Drug Registration Certificate Issued By China'S National Medical Products Administration (Nmpa). The Company Owns The Full Intellectual Property Rights Of The Drug.The Drug Is An Innovative Traditional Chinese Medicine (Tcm) Independently Developed By Yiling Pharmaceutical Based On Clinical Practices, Applicable To Mild And Moderate Depression With Symptoms Of Moodiness, Dysphoria, Loss Of Appetite, Insomnia And Dreaminess, Dizziness And Tinnitus, Etc.A Multicenter, Randomized, Double-Blind, Double-Simulated, Placebo-Fluoxetine Hydrochloride Tablet Controlled Clinical Trial Has Been Conducted For The Drug. The Results Showed That: According To The Decreased Values For Main Efficacy Indicators Of The Hamilton Depression Scale (Hamd-17) Scores From The Baseline, The Efficacy Of The Test Group Was Better Than That Of The Placebo Group, And Also Not Inferior To That Of The Fluoxetine Hydrochloride Tablet Group; With Batter Performance In The Scores For Individual Tcm Syndromes Such As Mental Depression, Restlessness, Insomnia And Dreaminess, Dizziness And Tinnitus As Well As In Hamilton Anxiety Scale (Hama) Scores.It Is Reported That 11 New Tcms Have Been Approved In China This Year, A New High In Recent Years, And The Two Innovative Patent Tcms Of "Depression-Resolving And Restlessness-Relieving Capsules" And "Kidney-Tonifying And Heart-Nourishing Tranquilization Tablets" Developed By Yiling Pharmaceutical Are In The List. Up To Now, Yiling Pharmaceutical Boasts 13 Patent Tcms, Covering Cardiovascular And Cerebrovascular Diseases, Respiratory Diseases, Tumors, Diabetes, Nervous System Diseases, Etc., Featuring Unique Product Portfolios. In Addition, The Tcm Of Lianhua Qingwen Capsules Has Become A Top Brand For Tackling Colds, And Tongxinluo Capsules, Shensong Yangxin Capsules And Qiliqiangxin Capsules Are The Leading Drugs For Treating Cardiovascular And Cerebrovascular Diseases.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!